2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Other
1
Lymphoid
1
Gastrointestinal
1
Conditions
Lymphoma
2981
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2496
Lymphoma, Non-Hodgkin
2265
Leukemia, Lymphocytic, Chronic, B-Cell
1992
Lymphoma, Follicular
1847
Lymphoma, Large B-Cell, Diffuse
1784
Leukemia
1339
Hodgkin Disease
1292
Lymphoma, Mantle-Cell
1193
Leukemia, Myeloid, Acute
978
Burkitt Lymphoma
955
Multiple Myeloma
866
Lymphoma, B-Cell, Marginal Zone
853
Recurrence
839
Lymphoma, B-Cell
754
Myelodysplastic Syndromes
682
Neoplasms
593
Lymphoma, T-Cell, Cutaneous
543
Waldenstrom Macroglobulinemia
514
Lymphoma, Large-Cell, Immunoblastic
490
Mycosis Fungoides
438
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
414
Lymphoma, Large-Cell, Anaplastic
390
Sezary Syndrome
364
Lymphoma, T-Cell, Peripheral
350
Hematologic Neoplasms
350
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
334
Myeloproliferative Disorders
328
Neoplasms, Plasma Cell
309
Blast Crisis
284
Interventions
Eye Movement Desensitization Reprocessing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Obsessive-Compulsive Disorder
×
Lymphoid
×
Clear all
NCT06110702
2024-04-16
MDL
University of Pisa
Phase NA
Completed
287 enrolled